Loading

JSM Clinical Case Reports

Neck Fusocellular Fibrosarcoma - A rare presentation of a rare disease

Case Report | Open Access | Volume 8 | Issue 1

  • 1. Department of General Surgery, Santa Luzia Hospital, Elvas, Portugal, Extremadura University, Spain
  • 2. Department of Anatomical Pathology, Espiríto Santo Hospital, Portugal
  • 3. Department of General Surgery, Santa Luzia Hospital, Portugal
+ Show More - Show Less
Corresponding Authors
Marta Reia, Department of General Surgery, Santa Luzia Hospital, Portugal, Tel: 00351910142993
Abstract

Sarcomas are an uncommon diversified group of neoplasms, which affects soft tissue: muscle, fatty tissue, lymphatics, blood vessels and nerves.

Soft tissue sarcomas (STS) accound for approximately 1% of all adults’ malignancies. They are hard to diagnose, requiring image exams, and imunohystochemical and molecular tests to confirm the diagnosis. The treatment is multidisciplinary, involving surgery, radiotherapy, chemotherapy, and monoclonal therapy, depending on the

Presenting stage of the disease.

This article reports a clinical case of a fusocellular fibrosarcoma in a 20-year-old female, presenting with a cervical indolent mass. The histologic exam revealed an incomplete excision of the lesion (R1) and it showed aspects related to a undifferentiated fusocellular fibros sarcoma, (G3).

This case was discussed in multidisciplinary consultation and the patient was referred to a Sarcoma Group in a terceary center, where a new surgery was performed for excision of the remaining disease. The anatomo-pathologic review showed a complete excision (R0), but with an insufficient margin, so that the patient was reoperated to obtain larger margins. The pathological exam of this new sample was negative for atypia. After surgical treatment, it was decided by the multidisciplinary team adjuvant treatment with radiotherapy. Follow-up: without evidence of disease relapse until today, eight years after diagnosis.

This case is relevant regarding the rarity of this tumors and the importance of obtaining sufficient margin to avoid relapse. We may remain unnoticed because of its indolent presentation, which can delay the diagnosis, several times presenting with advanced disease, reducing therapeutic options and survival.

Keywords

Neck soft tissue; Fibrosarcoma; Fusocellular f ibrosarcoma; Fusocellular mesenquimous sarcoma

Citation

Reia M, Quintana C, Santos CP (2020) Neck Fusocellular Fibrosarcoma - a rare presentation of a rare disease. JSM Clin Case Rep 8(1): 1174.

ABBREVIATIONS

STS: Soft tissue sarcomas; MRI: Magnetic Resonance Imaging; CTscan: Computorized Tomography Scan; WHO: World Health Organization, FNCLCC: French Fédération Nationale des Centre de Lutte Contre le Cancer, NCI: National Cancer; Institute, UICC: Union for International Cancer Control, AJCC: American Joint Committee on Cancer

INTRODUCTION

Sarcomas are uncommon diversified group of neoplasms, which affects soft tissue: muscle, fatty tissue, lymphatics, blood vessels and nerves. The anatomic distribution include the extremities (43%), the trunk (10%), visceral (19%), retroperitoneum (15%) or head and neck (9%) [1].

Soft tissue sarcomas (STS) accound for approximately 1% of all adults malignancies [1-3].

The true incidence of sarcomas is underestimated, in Europe being estimated in 4,5/1000 per year [4].

The main factor risks are hereditary syndromes like retinoblastom, neurofibromatosis type I, tuberous sclerosis, familiar adenomatosous poliposis, Gardner syndrome, LiFraumenni syndrome, Wegener syndrome and Gorlin Syndrome. Previous radiotherapy treatments are also an important risk factor.

The majority of sarcomas are clinically asymptomatic, but they can present as rapidly growing lesions, compressing nearby organs or spread in the form of secondary lesions.

STS have hematogenous spreading pattern and most commonly metastasizes to the lungs [1].

Soft tissue sarcomas are hard to diagnose, requiring image exams, and imunohystochemical and molecular tests to confirm the diagnosis. The treatment is multidisciplinary, involving surgery, radiotherapy, chemotherapy, and monoclonal therapy, depending on the stage of the disease.

CASE PRESENTATION

This case report: 20-year-old female patient, without previous medical or familiar history, whom was referred to consultation with a painless mass in the posterior cervical region. In the physical exam, this was an indurated mass, but not of petrous consistency, painless at palpation, but adherent to the superficial and deep surrounding tissue. No inflammatory sings were present, neither it was haemorrhagic.

As part of complementary study, the patient did an ultrasound which revealed an ovalated lesion, with 61mm in diameter, regular border, hypoecogenic, heterogeneous and with central vascularization.

Regarding the apparent benign sings described, the patient underwent surgical excision of this lesion, without complications.

The histologic exam revealed an incomplete excision of the lesion (R1) and it showed aspects related to a undiferentiated fusocellular fibrossarcoma, (G3). The detailed report revealed an infiltrative mesenquimatous pattern of proliferation, fusocellular, hypercelular and fasciculated, with moderate nuclear polymorphism; scattered proeminent nucleols, and fibro-hyalin stroma. There were necrotic areas, and a mitotic index of 30 figures / 10 hpf. (Figures 1-4).

Figure 1 Magnifying glass image: poorely delineated borders, with multinodular architecture, composed by hypercelular nodes, alternated with less cellular areas. The blue ink delineates the margin of surgical excision.

Figure 2 Microscope image: Neoplasic cells with light and eosinophilic cytoplasm, with poorly defined borders, ablongated and vesicular nucleolus, with fine cromatin and visible nucleolus.

Figure 3 Positive imuno-hystochemical analysis for marker BCL-2.

Figure 4 Positive imuno-hystochemical analysis for marker Vimentin.

The imuno-hystochemical study was positive for markers BCL-2, CD-99 and vimentin; it showed a Ki-67 of 25%. It was negative for markers pancytokeratin AE1/AE3, cytokeratina 7, cytokeratina 20, CAM5.2, S100, CD45, CD20, CD34, CD31, CD117, CD57 CD68, actin, desmin, myoglobin, EMA, FXIII and colagen IV. (Figures 3 and 4).

This case was then discussed in multidisciplinary consultation in the Hospital of Santa Luzia, Elvas, and it was decided to refer to a terciary center - Sarcoma Group Consultation, at the Portuguese Institute of Oncology, in Coimbra - for further treatment.

The patient underwent oncologic staging with cervical magnetic resonance (MRI) and thoraco-abdomino-pelvic CT scan. The cervical MRI showed subcicatricial residual lesion, 15x7mm, no signs of lymphatic invasion, nor other lesions; and the CT scan also excluded secondary disease.

After multidisciplinary evaluation, the decision was to perform new surgery for excision of the remaining disease. The anatomo-pathologic review showed a complete excision, but with an insufficient margin, and the patient was reoperated to obtain larger margins, which went without complications.

The pathological exam of this new sample was negative for atypia.

After this surgical treatment, it was decided by the multidisciplinary team adjuvante treatment with radiotherapy.

Until the present date, eight years after surgery, the patient remains us follow-up at the Sarcoma Group Consultation, with no further incidents.

DISCUSSION

Soft tissue chapter is one of the most complex and demanding of Pathological Anatomy, with multiple entities with distinct biologic behaviour. In 2013, the World Health Organization (WHO) established a new soft tissue tumors classification, stressing the detailed clinical, histological and genetic features of this tumors, made possible by the most recent information’s provided by cytogenetic and molecular. Additionally, this classification includes a revised categorization of biological behavior, which allows for two distinct types of intermediate malignancy [2].

Benign mesenchymal tumours outnumber sarcomas by at least 100. Soft tissue sarcomas become more frequent with increasing age, and about 10% of the patients present with detectable metastasis at the time of diagnosis, usually in the lungs [2].

The etiology is unknown, but multiple causes are referred, including genetic and environmental factors, irradiation, viral infections (HPV8, EBV) and immune deficiency.

Irrespectively of this causes, the majority of soft tissue sarcomas seem to arise de novo, without an apparent causative factor [2].

Clinically, these lesions commonly present as painless, accidentally detected tumors, without functional defects or repercussion in general health, despite the often large tumour volume.

These lesions are better characterized by magnetic resonance imaging (MRI), which has the ability to distinguish tumour tissue from adjacent muscle and fat, besides the information regarding the lesion size, relationship to muscle compartments, fascial planes, and bone and neurovascular structures. It also provides data about the instrinsic characteristics of the tumour (hemorrage, necrosis, edema, cystic and myxoid degeneration, and fibrosis).

The CT scan is performed at the time of the diagnosis, searching for the evidence of lung metastasis. PET is also a valuable exam, giving information regarding the biological activity of soft tissue masses.

The histologic characterization of these masses is of paramount importance, for the accurate diagnosis, tailored treatment, and prognostic implications. This is better obtained with a core biopsy, and fine needle aspiration is not usually performed, given its limited sampling.

The pathologic assessment of these samples is often difficult, so that several techniques have been used as an adjuvant to morphologic diagnosis (IHC, cytogenetics, molecular genetics).

The new WHO classification redefines the biological potential of these tumours, classifying them as benign, intermediate (locally agressive), intermediate (rarely malignant), and malignant.

Additionally, the histological grading of soft tissue tumours is obtained for its prognostic implications. The FNCLCC (French Fédération Nationale des Centre de Lutte Contre le Cancer) and NCI (United States National Cancer Institute) grading systems are the two most widely used systems for this purpose, providing a score and grade after evaluation of the tumour differentiation, mitotic rate and amount of tumour necrosis [1,2] With all this information, the disease may be staged. The major staging system used is the one developed by the Union for International Cancer Control (UICC) and the American Joint Committee on Cancer (AJCC), clinically useful and of prognostic value, using the TNM system [1,2].

Surgery remains the standard treatment of soft tissue tumours, but radiotherapy and chemotherapy are also often indicated, especially in bulkier and high-grade lesions. This approach is defined by an expert multidisciplinary team. A properly executed surgical resection is the most importante part of the overall treatment, with clear margins from tumour (preferentially >1cm), dictated by the size, anatomical location, relation with normal structures, and functional implications. The need for reconstructive surgical procedures may be considered. The margin status is the most important prognostic factor.

In areas where severe loss of function is likely, or the lesion is adjacent to major neurovascular bundles, the role of adjuvant or neoadjuvant radiotherapy and/or chemotherapy becomes more relevant, to downstage larger lesions and reduce the probability of local failure. More recentely, targeted therapy has also shown promising results in patients with certain histologic types of advanced or metastatic soft tissue tumours [1].

Fibrossarcoma represent about 10% of musculoskeletal sarcomas, diagnosed more commonly in patients in the fourth decade. It may present as a soft tissue mass or as a bone tumour. When it affects soft tissue, the age spectrum is wider [5].

As many other sarcomas, soft tissue fibrossarcoma often present as a painless mass, frequently arising deep to the muscular fascia, and may become extremely large until the diagnose is obtained [5].

Fibrossarcoma originates from mesenchymal cells, which transforms in tumors of malignant fibroblasts and collagen. Well-differentiated forms have multiple plump fibroblastos with deeply staining nulcei in a rich collagen background, but high grade lesions are very cellular, with marked cellular atypia and mitotic activity, with sparse Matrix [4].

The fusocellular variant is an uncommon variant within fibrossarcomas, with fish-bonelike cell fascicules. This kind of cell morphology is detected in many other sarcomas (malignant fibrous histiocytoma, leiomyosarcoma, monohpasic fase of synovial sarcoma, neurogenic sarcoma), and differential diagnosis is not always easy [6].

The treatment strategy is the the same as stated previously, requiring optimal biopsy and surgery, with appropriate margins. In soft tissue lesions, radiation therapy is often employed as adjuvant treament, while chemotherapy is used in higher grade lesions [5].

In this case report, the definitive diagnostic was a soft tissue fusocellular fibrossarcoma, stage IA: T1 N0 M0 G3 [FNCLCC score 7: Tumor undifferenciation 3 (high-grade), Mitotic count 3 (regarding >20 mitosis per 10hpf), Tumor necrosis 1 (<50% tumor necrosis)].

The initial approach has been the excision of a primitive lesion of the skin, which revealed the fibrossarcoma, followed by completion of resection requiring additional margin enlargement and adjuvant radiotherapy, with no signs of relapse until today.

ACKNOWLEDGEMENTS

We would like to show our gratitude to Dr. Carlos Quintana (Head of Department) from Anatomical Pathology Department of the Espírito Santo Hospital in Évora, Portugal, for providing the images of the histopathologic analysis of this case´s specimen.

Reia M, Quintana C, Santos CP (2020) Neck Fusocellular Fibrosarcoma - a rare presentation of a rare disease. JSM Clin Case Rep 8(1): 1174.

Received : 29 Apr 2020
Accepted : 30 May 2020
Published : 02 Jun 2020
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X